YTHDF2 inhibition potentiates radiotherapy antitumor efficacy
Cancer Cell · 2023-07 · 41 (7) · 1294-1308.e8
DOI: 10.1016/j.ccell.2023.04.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2023-07. Verfasst von Liangliang Wang und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA; Ludwig Center for Metastasis Research, University of Ch…. Hauptthemen laut MEDLINE: Neoplasms, NF-kappa B. Die Arbeit wurde bisher 246-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
RNA N6-methyladenosine (m6A) modification is implicated in cancer progression. However, the impact of m6A on the antitumor effects of radiotherapy and the related mechanisms are unknown. Here we show that ionizing radiation (IR) induces immunosuppressive myeloid-derived suppressor cell (MDSC) expansion and YTHDF2 expression in both murine models and humans. Following IR, loss of Ythdf2 in myeloid cells augments antitumor immunity and overcomes tumor radioresistance by altering MDSC differentiation and inhibiting MDSC infiltration and suppressive function. The remodeling of the landscape of MDSC populations by local IR is reversed by Ythdf2 deficiency. IR-induced YTHDF2 expression relies on NF-κB signaling; YTHDF2 in turn leads to NF-κB activation by directly binding and degrading transcripts encoding negative regulators of NF-κB signaling, resulting in an IR-YTHDF2-NF-κB circuit. Pharmacological inhibition of YTHDF2 overcomes MDSC-induced immunosuppression and improves combined IR and/or anti-PD-L1 treatment. Thus, YTHDF2 is a promising target to improve radiotherapy (RT) and RT/immunotherapy combinations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA; Ludwig Center for Metastasis Research, University of Chicago, Chicago, IL 60637, USA.
- Department of Chemistry, Department of Biochemistry and Molecular Biology, and Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL 60637, USA; Howard Hughes Medical Institute, University of Chicag…
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA; Ludwig Center for Metastasis Research, University of Chicago, Chicago, IL 60637, USA; The Committee on Clinical Pharmacology…
- Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.
- Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA; Ludwig Center for Metastasis Research, University of Chicago, Chicago, IL 60637, USA; Department of Neurosurgery, University…
Förderung
- NHGRI NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- Howard Hughes Medical Institute
Zitieren
APA
Wang, L., Dou, X., Chen, S., Yu, X., Huang, X., Zhang, L., Chen, Y., Wang, J., Yang, K., Bugno, J., Pitroda, S., Ding, X., Piffko, A., Si, W., Chen, C., Jiang, H., Zhou, B., Chmura, S. J., Luo, C., …, & Weichselbaum, R. R. (2023). YTHDF2 inhibition potentiates radiotherapy antitumor efficacy. Cancer Cell, 41(7), 1294-1308.e8. https://doi.org/10.1016/j.ccell.2023.04.019
Vancouver
Wang L, Dou X, Chen S, Yu X, Huang X, Zhang L, et al. YTHDF2 inhibition potentiates radiotherapy antitumor efficacy. Cancer Cell. 2023;41(7):1294-1308.e8. doi:10.1016/j.ccell.2023.04.019
BibTeX
@article{Wang2023,
author = {Wang, Liangliang and Dou, Xiaoyang and Chen, Shijie and Yu, Xianbin and Huang, Xiaona and Zhang, Linda and Chen, Yantao and Wang, Jiaai and Yang, Kaiting and Bugno, Jason and Pitroda, Sean and Ding, Xingchen and Piffko, Andras and Si, Wei and Chen, Chao and Jiang, Hualiang and Zhou, Bing and Chmura, Steven J and Luo, Cheng and Liang, Hua Laura and He, Chuan and Weichselbaum, Ralph R},
title = {YTHDF2 inhibition potentiates radiotherapy antitumor efficacy},
journal = {Cancer Cell},
year = {2023},
volume = {41},
number = {7},
pages = {1294--1308.e8},
doi = {10.1016/j.ccell.2023.04.019}
}
EUVIMED